Cargando…

The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma

Primary mediastinal B-cell lymphoma (PMBL) is a subtype of diffuse large B-cell lymphoma (DLBCL) that arises in the mediastinum from B-cells of thymic origin. Optimal management of patients with PMBL remains controversial. The present study evaluates outcomes of 27 PMBL patients treated with R-CHOP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagle, Sarah J, Chong, Elise A, Chekol, Seble, Shah, Nirav N, Nasta, Sunita D, Glatstein, Eli, Plastaras, John P, Torigian, Drew A, Schuster, Stephen J, Svoboda, Jakub
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312112/ https://www.ncbi.nlm.nih.gov/pubmed/25205600 http://dx.doi.org/10.1002/cam4.322

Ejemplares similares

Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS
por: Nagle, Sarah J, et al.
Publicado: (2017)

Salvage radiotherapy for relapsed/refractory non‐Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy
por: Yegya-Raman, Nikhil, et al.
Publicado: (2023)

Characterization of Mediastinal Bulky Lymphomas with FDG-PET-Based Radiomics and Machine Learning Techniques
por: Abenavoli, Elisabetta Maria, et al.
Publicado: (2023)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

Safety and Efficacy of Sars-Cov-2 Vaccines in Hodgkin Lymphoma Patients Receiving PD-1 Inhibitors
por: Svoboda, Jakub, et al.
Publicado: (2021)

FDG-PET parameters predicting mediastinal malignancy in lung cancer
por: Serra Fortuny, M., et al.
Publicado: (2016)

FDG-PET/CT in lymphoma
por: D'souza, Maria M, et al.
Publicado: (2013)

Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas
por: Svoboda, Jakub, et al.
Publicado: (2020)

Primary mediastinal B-cell lymphoma – metabolic and anatomical features in 18FDG-PET/CT and response to therapy
por: Kocurek, Anna, et al.
Publicado: (2016)

FDG-PET in Follicular Lymphoma Management
por: Bodet-Milin, C., et al.
Publicado: (2012)

The role of FDG-PET in Hodgkin lymphoma
por: Subocz, Edyta, et al.
Publicado: (2017)

Metabolic Characterization of Anterior Mediastinal Masses by (18)F-FDG PET/CT
por: Koç, Zehra Pınar, et al.
Publicado: (2020)

Prediction of lymphoma response to CAR T cells by deep learning-based image analysis
por: Tong, Yubing, et al.
Publicado: (2023)

Hepatic granuloma mimicking recurrent lymphoma on (18)F-FDG PET/CT in a patient with primary mediastinal diffuse large B-cell lymphoma
por: Akkawi, Abdul Rahman, et al.
Publicado: (2022)

Gross Tumor Delineation in Esophageal Cancer on MRI Compared With (18)F-FDG-PET/CT
por: Vollenbrock, Sophie E., et al.
Publicado: (2019)

18-FDG PET/CT assessment of basal cell carcinoma with vismodegib
por: Thacker, Curtis A, et al.
Publicado: (2012)

Pulmonary intravascular lymphoma detected by FDG‐PET
por: Nada, Takahiro, et al.
Publicado: (2017)

Sarcoidosis mimicking lymphoma on FDG-PET imaging
por: Shetty, Anjali, et al.
Publicado: (2015)

Assessment of Mediastinal Tumors Using SUV(max) and Volumetric Parameters on FDG-PET/CT
por: Morita, Takahiro, et al.
Publicado: (2017)

Diagnosis of an unusual case of idiopathic mediastinal fibrosis by (18)F-FDG PET/CT
por: Carbone, Roberto G., et al.
Publicado: (2020)

18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation
por: David, John M., et al.
Publicado: (2019)

Radiomics based on (18)F‐FDG PET/CT could differentiate breast carcinoma from breast lymphoma using machine‐learning approach: A preliminary study
por: Ou, Xuejin, et al.
Publicado: (2019)

FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer
por: Chen, James L, et al.
Publicado: (2013)

Overview of early response assessment in lymphoma with FDG-PET
por: MacManus, Michael P, et al.
Publicado: (2007)

On the Added Value of Baseline FDG-PET in Malignant Lymphoma
por: Quarles van Ufford, Henriette, et al.
Publicado: (2009)

Interest of FDG-PET in the Management of Mantle Cell Lymphoma
por: Bailly, Clément, et al.
Publicado: (2019)

Comparative study of (18)F-FDG-PET/CT imaging and serum hTERT mRNA quantification in cancer diagnosis
por: Ping, Bingqiong, et al.
Publicado: (2015)

A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma
por: Milgrom, Sarah A., et al.
Publicado: (2019)

Primary mediastinal lymphomas, their morphological features and comparative evaluation
por: Aggarwal, Riti, et al.
Publicado: (2017)

Comparative Role of MDCT and FDG-PET/CT in the Diagnostic Evaluation of Mediastinal Mass Lesions: An Institutional Experience
por: Reddy, Ravikanth
Publicado: (2022)

(18)F-FDG PET/CT Showing Rare Mediastinal Growing Teratoma Syndrome Following Chemotherapy
por: Sasahara, Mihoko, et al.
Publicado: (2022)

Radiation Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: What Is the Right Regimen for Palliation?
por: Wright, Christopher M., et al.
Publicado: (2022)

Radiomics-guided therapy for bladder cancer: Using an optimal biomarker approach to determine extent of bladder cancer invasion from t2-weighted magnetic resonance images
por: Tong, Yubing, et al.
Publicado: (2018)

Serum level of soluble interleukin‐2 receptor is positively correlated with metabolic tumor volume on (18)F‐FDG PET/CT in newly diagnosed patients with diffuse large B‐cell lymphoma
por: Senjo, Hajime, et al.
Publicado: (2019)

Utilizing (18)F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
por: Momcilovic, Milica, et al.
Publicado: (2018)

Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats
por: André, M., et al.
Publicado: (2011)

Utility of FDG PET/CT in the Management of Primary Testicular Lymphoma
por: Okuyucu, Kürşat, et al.
Publicado: (2018)

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
por: Barrington, Sally F., et al.
Publicado: (2017)

CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab
por: Skougaard, Kristin, et al.
Publicado: (2014)

Evaluation of mediastinal lymph nodes using (18)F-FDG PET-CT scan and its histopathologic correlation
por: Kumar, Arvind, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_pb5edc201642ebk9pm79udam96